To Conquer HIV, We Need To Treat Injection Drug Users

Huge advances have been made in the treatment of HIV and AIDS. In our lifetimes, we witnessed the emergence of this global pandemic. We then watched as researchers developed anti-retroviral therapies that not only turned this devastating infection into one that was treatable, but that also vastly reduced disease transmission by reducing viral load to undetectable levels in the blood of infected patients.

These 5 BC-CfE Findings Challenge Assumptions on Drug Use and Public Health

List by Caroline Dobuzinskis at the British Columbia Centre for Excellence in HIV and AIDS, reprinted with permission. Read the original post here.

1. Supervised injection sites prevent needle sharing

A 2001 study found, despite the availability of a large needle-exchange program and targeted law enforcement efforts in Vancouver, needle sharing was still an alarmingly common practice. The researchers suggested the trend could be stemmed through access to safe injection sites, by alleviating the factors leading to more risky behaviours such as difficulty in getting needles.

Supporting this recommendation, a 2005 study published in The Lancet found the use of safe injection sites was associated with a reduction of close to 70% in the probability of syringe sharing. A 2011 paper published in The Lancet found Insite to be associated with a 35% reduction in overdose deaths in the area surrounding the supervised injection facility.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below